Characterization of the Motivational Deficit in Schizophrenia and Depression
SCHIZOBAT
SCHIZOBAT/DEPBAT : Characterization of the Motivational Deficit in Schizophrenia and Depression
1 other identifier
interventional
140
1 country
1
Brief Summary
This research focuses on disorders of motivation, responsible for a disability that patients experience daily. It is a disorder that affects behavior, especially social. Mechanisms, which result in these disorders, are poorly understood. This ignorance is responsible for the lack of effective therapy. The investigators realize this work in order to better understand the motivational deficits. The objective of the study is to characterize the cognitive mechanisms of motivational deficits in schizophrenia and depression. To answer the question posed in the research, it is planned to include 35 people with schizophrenia, 35 people with depression and 70 heathy volunteers in the Hospital of Sainte-Anne .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable schizophrenia
Started Nov 2014
Typical duration for not_applicable schizophrenia
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 13, 2014
CompletedStudy Start
First participant enrolled
November 21, 2014
CompletedFirst Posted
Study publicly available on registry
March 4, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2019
CompletedJanuary 25, 2018
October 1, 2017
3.9 years
August 13, 2014
January 23, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
level of force produced based in incentive reward
the first inclusion day
level of force produced based in incentive reward
up to third day
Secondary Outcomes (3)
consistent level of choice questionnaire
the first inclusion day
The proportion of choosing the expensive option (great effort/big time/immediate effort)
the first inclusion day
The proportion of corrects choice
the first inclusion day
Study Arms (4)
Schizophrenia patients
OTHER35 patients, Age between 18 and 65 years, with a diagnosis of schizophrenia and unchanged psychotropic treatment for at least three months before inclusion.
Healthy volunteers (schizophrenia)
OTHER35 healthy volunteers
Depressive patients
OTHERHealthy volunteers (depression)
OTHERInterventions
Force task, preference task, discount task, learning task.
Eligibility Criteria
You may qualify if:
- Patients :
- Age between 18 and 65 years
- Affiliation to a healthy insurance
- Subjects who were informed and willing to sign the form of free and informed consent and information of the curator if necessary (or consent of the tutor)
- French native tongue
- Diagnosis of schizophrenia according to ICD-10, made by a psychiatrist. The subjects are stabilized (less than three items include a score\> = 4 or to the positive level (P) of the PANSS)
- Healthy volunteers:
- Age between 18 and 65 years
- Affiliation to a healthy insurance
- Subjects who were informed and willing to sign the form of free and informed consent and information curator appropriate
- French native tongue
You may not qualify if:
- Patients:
- Unable major, persons deprived of liberty, pregnant women
- Enforced hospitalisation
- Recent abuse (1 week) or chronic use of addictive substances, except tobacco
- Treatment electro-convulsivo-therapy in the last 6 months
- Degenerative Pathology, neurological disorder
- Co-occurrence of a major depressive episode in a schizophrenic patient evaluated by a score\> 10 CDS
- Difficulty in understanding and expression in French language
- Deficit of visual acuity or uncorrected hearing
- Healthy volunteers:
- Unable major, persons deprived of liberty, pregnant women
- Current psychiatric disease
- Psychotropic treatment
- Recent abuse (1 week) or chronic use of addictive substances, except tobacco
- Difficulty in understanding and expression in French language
- +28 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier Sainte Anne
Paris, 75014, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Raphaël GAILLARD, MD, PhD
Centre Hospitalier St Anne
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 13, 2014
First Posted
March 4, 2015
Study Start
November 21, 2014
Primary Completion
November 1, 2018
Study Completion
January 1, 2019
Last Updated
January 25, 2018
Record last verified: 2017-10